An unprecedented structural motif for metallaboranes is exhibited by the anion [{HFe(MeSiB10H10)}2]2− (see picture), which was isolated as the {nBu4N}2 salt in 63% yield from the reaction of deprotonated sila‐nido‐undecaborate and FeBr2.
Complexation of the silaborate ligand
[MeSiB10H10]3- is
described for the first time. The syntheses of the
sandwich
anions
[(η5-C5Me5)M(MeSiB10H10)]-
(M = Co, Rh, Ir) are realized by reaction of the monodeprotonated
silaborate
with the respective pentamethylcyclopentadienyl transition metal
chloride. The reaction products are characterized
by mass spectrometry, elemental analyses, and multinuclear and
two-dimensional NMR spectroscopy. Because
of an unresolvable disorder in the solid state structure of
[NEt4][(η5-C5Me5)Rh(MeSiB10H10)],
the isobutyl-substituted derivative
[Ph3PMe][(η5-C5BuiMe4)Rh(MeSiB10H10)],
[Ph3PMe][4], was analyzed by an
X-ray structure
determination. The salt
[Ph3PMe][4]·THF,
C37H60OPSiB10Rh,
crystallizes in the triclinic space group P1̄ (No.
2)
with a = 9.838(4) Å, b = 11.312(3)
Å, c = 18.858(5) Å, α = 92.68(2)°, β
= 90.22(3)°, γ = 96.77(3)°, and
Z = 2.
Eine für Metallaborane beispiellose Struktur hat das Anion [{HFe‐(MeSiB10H10)}2]2−, das als Tetrabutylammoniumsalz in 63% Ausbeute bei der Reaktion von deprotoniertem Sila‐nido‐undecaborat mit FeBr2 erhalten wird.
The geometry of the Si B framework remains nearly unchanged when the Si-Si edge is bridged by an electron-donating amido group. This finding is clearly evident from the single-crystal X-ray structure analysis and ab initio calculations of the uprecedented adduct that is formed by the addition of Et N to o-silaborane (structure depicted bottom right).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.